Geisinger is offering COVID-19 vaccine boosters to help shield against omicron variants
DANVILLE, Pa. – Following recent guidance from the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), Geisinger is offering single booster doses of the Pfizer/BioNTech COVID-19 bivalent booster vaccine for people age 12 and older.
The updated vaccine booster dose includes an mRNA component of the original strain to provide an immune response to protect against COVID-19 and the newer omicron variants (BA.4 and BA.5).
Those eligible for a booster shot can make an appointment at a Geisinger Pharmacy location via MyGeisinger, the MyChart mobile app, or by calling 570-284-3657.
Remember to bring your COVID-19 vaccine card or proof of having received the vaccine to your appointment. More information about the COVID-19 vaccine is available at geisinger.org/covidvax.
The updated vaccine booster dose includes an mRNA component of the original strain to provide an immune response to protect against COVID-19 and the newer omicron variants (BA.4 and BA.5).
Those eligible for a booster shot can make an appointment at a Geisinger Pharmacy location via MyGeisinger, the MyChart mobile app, or by calling 570-284-3657.
Remember to bring your COVID-19 vaccine card or proof of having received the vaccine to your appointment. More information about the COVID-19 vaccine is available at geisinger.org/covidvax.
About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.